Monocyte-to-High-Density Lipoprotein Ratio Predicts the Outcome of Acute Ischemic Stroke

Hongbing Liu1, Kai Liu1, Lulu Pei1

  • 1Department of Neurology, the First Affiliated Hospital of Zhengzhou University.

Abstract

Insights

The monocyte-to-high-density lipoprotein ratio (MHR) may predict poor outcomes in acute ischemic stroke (AIS) patients. Higher MHR levels were independently associated with worse functional outcomes at three months post-stroke.

Area of Science:

  • Cardiology
  • Neurology
  • Inflammation Markers

Background:

  • The monocyte-to-high-density lipoprotein ratio (MHR) is an emerging inflammatory marker.
  • MHR has shown prognostic value in cardiovascular diseases.
  • The prognostic significance of MHR in acute ischemic stroke (AIS) is not well-established.

Purpose of the Study:

  • To investigate the association between MHR and functional outcomes in patients with AIS.
  • To determine if MHR can serve as an independent predictor of poor outcomes after AIS.

Main Methods:

  • Prospective cohort study of 1090 AIS patients from January 2015 to December 2017.
  • Functional outcome assessed using the modified Rankin Scale (mRS) at 3 months; poor outcome defined as mRS 3-6.
  • Multivariate logistic regression and Receiver Operating Curve (ROC) analysis were employed.

Main Results:

  • MHR was significantly higher in patients with poor outcomes compared to those with good outcomes (0.53 vs. 0.48, P=0.007).
  • Elevated MHR was independently associated with poor functional outcome at 3 months (OR 2.58, P=0.015), particularly in large artery atherosclerosis stroke.
  • The optimal MHR cutoff for predicting poor outcome was 0.51, with 62.3% sensitivity and 66.5% specificity (AUC=0.67).

Conclusions:

  • MHR is a significant predictor of poor functional outcomes in AIS patients.
  • MHR may serve as an independent prognostic marker for AIS prognosis.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
521
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
159
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
543
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
701
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
280